Clearway Capital Calls for Overhaul at Evolva

Clearway Capital GmbH, the largest shareholder of Evolva Holding SA, urges substantial changes at the Swiss company due to significant shareholder value losses. Evolva's share price has plunged by about 98% since the current board members took office, prompting investors to lose almost all their capital. Despite the decline, the management and board received CHF 9.3 million in compensation, raising shareholder concerns.

At the forthcoming Annual General Meeting on March 27, 2025, Clearway plans to propose a new board of directors for strategic improvement. Their strategy focuses on maximizing Evolva's assets, broadening transaction scopes beyond healthcare, and enhancing governance. Clearway aims to drive sustainable value creation by eliminating Evolva's cash burn and prioritizing profitable, low-risk ventures.

Gianluca Ferrari, Founder of Clearway Capital, emphasizes the need for competent leadership at Evolva to navigate the proposed changes.